Nuvectis Pharma, Inc. — Director's Dealing 2024

Dec 16, 2024

SEC Form 4/A — Form 4/A

Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2024-12-12

Reporting Person: Mosseri Marlio Charles (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-12	Common Stock	P	32121	$4.64	Acquired	2627121	Direct
2024-12-13	Common Stock	P	17000	$4.70	Acquired	2644121	Direct

Footnotes

F1: The original Form 4, filed on December 16, 2024, is being amended by this Form 4 amendment to include a transaction that occurred on December 12, 2024, and to correct the amount of securities beneficially owned by the reporting person as a result of the reported transactions.